SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001847903-22-000049
Filing Date
2022-08-10
Accepted
2022-08-10 06:58:00
Documents
58
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cnta-20220630.htm   iXBRL 10-Q 1811152
2 EX-31.1 a20220630exhibit311.htm EX-31.1 10044
3 EX-31.2 a20220630exhibit312.htm EX-31.2 12219
4 EX-32.1 a20220630exhibit321.htm EX-32.1 5343
5 EX-32.2 a20220630exhibit322.htm EX-32.2 5157
  Complete submission text file 0001847903-22-000049.txt   5753932

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cnta-20220630.xsd EX-101.SCH 32453
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cnta-20220630_cal.xml EX-101.CAL 45600
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cnta-20220630_def.xml EX-101.DEF 190190
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cnta-20220630_lab.xml EX-101.LAB 453153
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cnta-20220630_pre.xml EX-101.PRE 307703
52 EXTRACTED XBRL INSTANCE DOCUMENT cnta-20220630_htm.xml XML 698897
Mailing Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT
Business Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT 44 7391 789784
Centessa Pharmaceuticals plc (Filer) CIK: 0001847903 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40445 | Film No.: 221150349
SIC: 2834 Pharmaceutical Preparations